Premature ovarian failure

Journal of Family Planning and Reproductive Health Care

Volumn 37, Issue 1, 2011, Pages 35-42

  Maclaran, Kate ^a   Panay, Nick ^a  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN;

AMENORRHEA; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CHROMOSOME DISORDER; COGNITIVE DEFECT; CONTRACEPTION; CRYOPRESERVATION; DIET; DIETARY INTAKE; ESTROGEN DEFICIENCY; ETHNIC DIFFERENCE; FERTILITY; FMR1 GENE; GENE; GENE MUTATION; HEREDITY; HORMONE SUBSTITUTION; HUMAN; IATROGENIC DISEASE; LIFESTYLE MODIFICATION; MUMPS; OSTEOPOROSIS; PREMATURE OVARIAN FAILURE; PSYCHOLOGICAL ASPECT; REVIEW;

CARDIOVASCULAR DISEASES; COGNITION DISORDERS; CONTRACEPTION BEHAVIOR; COUNSELING; FEMALE; FERTILITY; HORMONE REPLACEMENT THERAPY; HUMANS; LIFE STYLE; OSTEOPOROSIS; PRIMARY OVARIAN INSUFFICIENCY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 79952000304     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1136/jfprhc.2010.0015     Document Type: Review

References (53)

1. Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 2008;68:499-509. (Pubitemid 351388699)
2. Kalu E, Panay N. Spontaneous premature ovarian failure: management challenges. Gynecol Endocrinol 2008;24:273-279. (Pubitemid 351891657)
3. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606.
4. Luborsky JL, Meyer P, Sowers MF, et al. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003;18:199-206. (Pubitemid 36138877)
5. Panay N, Fenton A. Premature ovarian failure: a growing concern. Climacteric 2008;11:1-3.
6. Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006;91:1723-1728.
7. Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006;98:890-896. (Pubitemid 44018918)
8. Chang SH, Kim CS, Lee KS, et al. Premenopausal factors influencing premature ovarian failure and early menopause. Maturitas 2007;58:19-30. (Pubitemid 47268703)
9. Rebar RW, Erickson GF, Yen SS. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 1982;37:35-41. (Pubitemid 12207214)
10. Schlessinger D, Herrera L, Crisponi L, et al. Genes and translocations involved in POF. Am J Med Genet 2002;111:328-333.
11. Rees M, Purdie D. Premature menopause. In: Management of the Menopause: The Handbook (4th edn). London, UK: Royal Society of Medicine Press Ltd, 2006;142-149.
12. Novosad JA, Kalantaridou SN, Tong ZB, et al. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health 2003;3:2.
13. Morrison JC, Givens JR, Wiser WL, et al. Mumps oophoritis: a cause of premature menopause. Fertil Steril 1975;26:655-659.
14. Green DM, Sklar CA, Boice JD Jr, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol 2009;27:2374-2381.
15. Panay N, Maclaran K, Nicopollous J, Horner E, Domoney C. Findings from the West London Menopause and PMS Centre POF Database (Abstract No. 337). Proceedings of the 32nd British International Congress of Obstetrics and Gynaecology, Belfast, Northern Ireland, UK, 20-23 June 2010.
16. Alzubaidi NH, Chapin HL, Vanderhoof VH, et al. Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol 2002;99:720-725. (Pubitemid 34442446)
17. Popat VB, Calis KA, Vanderhoof VH, et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab 2009;94:2277-2283.
18. Tehrani A, Shakeri N, Azizi F. Whether age at menopause is predictable using serum anti-Mullerian hormone concentration? Hum Reprod 2010;25:i1-i3.
19. Sowers MR, Eyvazzadeh AD, McConnell D, et al. Antimullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478-3483.
20. British Menopause Society (BMS). Premature Menopause. British Menopause Society Council Consensus Statement. 2007. http://www.thebms.org.uk/ statementpreview.php?id=3 [accessed 14 September 2010].
21. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomised controlled trial. JAMA 2002;288:321-333.
22. van der Stege JG, Groen H, van Zadelhoff SJ, et al. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause 2008;15:23-31.
23. Parke S, Nahum G, Mellinger U. Metabolic effects of a new four-phasic oral contraceptive containing estradiol valerate and dienogest. Obstet Gynecol 2008;111:12S-13S.
24. Cartwright B, Robinson J, Rymer J. Treatment of premature ovarian failure trial: description of an ongoing clinical trial. Menopause Int 2010;16:18-22.
25. van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5:483-492. (Pubitemid 29512134)
26. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:804-810. (Pubitemid 20180467)
27. Schmidt PJ, Cardoso GM, Ross JL, et al. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA 2006;295:1374-1376.
28. Liao KL, Wood N, Conway GS. Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol 2000;21:167-174.
29. Singer D, Mann E, Hunter M, et al. The silent grief: psychological aspects of premature ovarian failure. Poster presentation at the 6th Amsterdam Menopause and Women's Health Symposium, Amsterdam, The Netherlands, 26-28 September 2010.
30. Graziottin A, Basson R. Sexual dysfunction in women with premature menopause. Menopause 2004;11:766-777.
31. Ossewaarde ME, Bots ML, Verbeek AL, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005;16:556-562. (Pubitemid 40847843)
32. Cooper GS, Sandler DP. Age at natural menopause and mortality. Ann Epidemiol 1998;8:229-235.
33. Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003;157:923-929. (Pubitemid 36555052)
34. Anasti JN, Kalantaridou SN, Kimzey LM, et al. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1998;91:12-15. (Pubitemid 28042325)
35. Uygur D, Sengül O, Bayar D, et al. Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet 2005;273:17-19. (Pubitemid 41571162)
36. van Der Voort DJ, van Der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int 2003;14:525-530. (Pubitemid 36919215)
37. van der Klift M, de Laet CE, McCloskey EV, et al. Risk factors for incident vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 2004;19:1172-1180. (Pubitemid 41110570)
38. Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 1999;52:303-307. (Pubitemid 29305302)
39. Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004;89:3907-3913. (Pubitemid 39071493)
40. Knauff EA, Westerveld HE, Goverde AJ, et al. Lipid profile of women with premature ovarian failure. Menopause 2008;15:919-923.
41. Corrigan EC, Nelson LM, Bakalov VK, et al. Effects of ovarian failure and X-chromosome deletion on body composition and insulin sensitivity in young women. Menopause 2006;13:911-916. (Pubitemid 44760383)
42. Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 2010;65:262-266.
43. Chu MC, Rath KM, Huie J, et al. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod 2003;18:1570-1573. (Pubitemid 36958032)
44. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-1083. (Pubitemid 47517552)
45. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008;70:200-209.
46. Tartagni M, Cicinelli E, De Pergola G, et al. Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril 2007;87:858-861. (Pubitemid 46566354)
47. Mamas L, Mamas E. Premature ovarian failure and dehydroepiandrosterone. Fertil Steril 2009;91:644-646.
48. Nyboe Andersen A, Goossens V, Bhattacharya S, et al.; European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 2009;24:1267-1287.
49. Noyes N, Labella PA, Grifo J, et al. Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. J Assist Reprod Genet 2010;27:495-499.
50. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006;86:70-80.
51. Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-1410. (Pubitemid 39370715)
52. Demeestere I, Simon P, Emiliani S, et al. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist 2007;12:1437-1442.
53. Cooper AR, Baker VL, Sterling EW, et al. The time is now for a new approach to primary ovarian insufficiency. Fertil Steril 2010; doi:10.1016/j.fertnstert.2010.01.016.